Annual EBITDA:
-$58.55M+$13.86M(+19.14%)Summary
- As of today, LENZ annual EBITDA is -$58.55 million, with the most recent change of +$13.86 million (+19.14%) on December 31, 2024.
- During the last 3 years, LENZ annual EBITDA has risen by +$1.16 million (+1.94%).
- LENZ annual EBITDA is now -201803.45% below its all-time high of -$29.00 thousand, reached on December 1, 2019.
Performance
LENZ EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$18.76M-$1.92M(-11.43%)Summary
- As of today, LENZ quarterly EBITDA is -$18.76 million, with the most recent change of -$1.92 million (-11.43%) on September 30, 2025.
- Over the past year, LENZ quarterly EBITDA has dropped by -$5.83 million (-45.05%).
- LENZ quarterly EBITDA is now -15405.79% below its all-time high of -$121.00 thousand, reached on March 1, 2020.
Performance
LENZ Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$67.69M-$5.83M(-9.42%)Summary
- As of today, LENZ TTM EBITDA is -$67.69 million, with the most recent change of -$5.83 million (-9.42%) on September 30, 2025.
- Over the past year, LENZ TTM EBITDA has increased by +$642.00 thousand (+0.94%).
- LENZ TTM EBITDA is now -55846.28% below its all-time high of -$121.00 thousand, reached on March 1, 2020.
Performance
LENZ TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LENZ EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +19.1% | -45.0% | +0.9% |
| 3Y3 Years | +1.9% | +21.8% | +26.2% |
| 5Y5 Years | -10000.0% | -398.5% | -1207.9% |
LENZ EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +39.8% | -48.8% | +24.9% | -15.6% | +30.4% |
| 5Y | 5-Year | >-9999.0% | +39.8% | -398.5% | +24.9% | -1207.9% | +30.4% |
| All-Time | All-Time | >-9999.0% | +39.8% | >-9999.0% | +24.9% | >-9999.0% | +30.4% |
LENZ EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$18.76M(-11.4%) | -$67.69M(-9.4%) |
| Jun 2025 | - | -$16.84M(+0.3%) | -$61.87M(-4.2%) |
| Mar 2025 | - | -$16.89M(-11.2%) | -$59.36M(-1.4%) |
| Dec 2024 | -$58.55M(+19.1%) | -$15.20M(-17.5%) | -$58.55M(+14.3%) |
| Sep 2024 | - | -$12.94M(+9.8%) | -$68.34M(+9.2%) |
| Jun 2024 | - | -$14.33M(+10.9%) | -$75.26M(+0.8%) |
| Mar 2024 | - | -$16.08M(+35.6%) | -$75.88M(-4.8%) |
| Dec 2023 | -$72.41M(+25.6%) | -$24.98M(-25.8%) | -$72.41M(-0.6%) |
| Sep 2023 | - | -$19.86M(-32.8%) | -$71.96M(+5.4%) |
| Jun 2023 | - | -$14.96M(-18.6%) | -$76.08M(+11.4%) |
| Mar 2023 | - | -$12.61M(+48.6%) | -$85.84M(+11.8%) |
| Dec 2022 | -$97.29M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | - | -$24.53M(-2.3%) | -$97.29M(-6.1%) |
| Sep 2022 | - | -$23.99M(+2.9%) | -$91.70M(-12.2%) |
| Jun 2022 | - | -$24.71M(-2.7%) | -$81.76M(-9.8%) |
| Mar 2022 | - | -$24.07M(-27.1%) | -$74.48M(-24.8%) |
| Dec 2021 | -$59.71M(-346.3%) | -$18.94M(-34.8%) | -$59.70M(-21.9%) |
| Sep 2021 | - | -$14.05M(+19.4%) | -$48.96M(-26.6%) |
| Jun 2021 | - | -$17.43M(-87.9%) | -$38.68M(-71.6%) |
| Mar 2021 | - | -$9.28M(-13.1%) | -$22.54M(-68.4%) |
| Dec 2020 | -$13.38M(>-9900.0%) | -$8.20M(-117.9%) | -$13.38M(-158.5%) |
| Sep 2020 | - | -$3.76M(-191.6%) | -$5.18M(-266.6%) |
| Jun 2020 | - | -$1.29M(-966.9%) | -$1.41M(-1066.9%) |
| Mar 2020 | - | -$121.00K | -$121.00K |
| Dec 2019 | -$29.00K | - | - |
FAQ
- What is LENZ Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for LENZ Therapeutics, Inc.?
- What is LENZ Therapeutics, Inc. annual EBITDA year-on-year change?
- What is LENZ Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for LENZ Therapeutics, Inc.?
- What is LENZ Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is LENZ Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for LENZ Therapeutics, Inc.?
- What is LENZ Therapeutics, Inc. TTM EBITDA year-on-year change?
What is LENZ Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of LENZ is -$58.55M
What is the all-time high annual EBITDA for LENZ Therapeutics, Inc.?
LENZ Therapeutics, Inc. all-time high annual EBITDA is -$29.00K
What is LENZ Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, LENZ annual EBITDA has changed by +$13.86M (+19.14%)
What is LENZ Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of LENZ is -$18.76M
What is the all-time high quarterly EBITDA for LENZ Therapeutics, Inc.?
LENZ Therapeutics, Inc. all-time high quarterly EBITDA is -$121.00K
What is LENZ Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, LENZ quarterly EBITDA has changed by -$5.83M (-45.05%)
What is LENZ Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of LENZ is -$67.69M
What is the all-time high TTM EBITDA for LENZ Therapeutics, Inc.?
LENZ Therapeutics, Inc. all-time high TTM EBITDA is -$121.00K
What is LENZ Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, LENZ TTM EBITDA has changed by +$642.00K (+0.94%)